Orbimed Advisors - LOGICBIO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,307,000
-22.2%
8,466,7830.0%0.04%
-20.4%
Q2 2022$2,967,000
-48.5%
8,466,7830.0%0.05%
-41.9%
Q1 2022$5,758,000
-70.6%
8,466,7830.0%0.09%
-62.9%
Q4 2021$19,558,000
-49.6%
8,466,7830.0%0.25%
-41.1%
Q3 2021$38,778,000
+3.2%
8,466,7830.0%0.43%
+12.1%
Q2 2021$37,593,000
-39.0%
8,466,7830.0%0.38%
-34.0%
Q1 2021$61,638,000
-4.6%
8,466,7830.0%0.58%
+1.9%
Q4 2020$64,602,000
+10.0%
8,466,783
+30.9%
0.56%
-23.4%
Q3 2020$58,718,000
+7.3%
6,466,7830.0%0.74%
-4.2%
Q2 2020$54,709,000
+71.3%
6,466,7830.0%0.77%
+43.4%
Q1 2020$31,946,000
-31.4%
6,466,7830.0%0.54%
-19.2%
Q4 2019$46,561,000
-33.4%
6,466,7830.0%0.66%
-49.8%
Q3 2019$69,906,000
-16.8%
6,466,7830.0%1.33%
+1.8%
Q2 2019$84,068,000
+31.6%
6,466,7830.0%1.30%
+31.6%
Q1 2019$63,892,000
-5.0%
6,466,7830.0%0.99%
-20.5%
Q4 2018$67,255,0006,466,7831.24%
Other shareholders

There were no reported owners of LOGICBIO THERAPEUTICS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of LOGICBIO THERAPEUTICS INC shareholders